Literature DB >> 10535644

Factors affecting the course and severity of transnasally induced Staphylococcus aureus pneumonia in mice.

Kazuhiro Kimura1, Shuichi Miyazaki2, Kazuhiro Tateda2, Tetsuya Matsumoto2, Shirou Tsujimoto3, Keizo Yamaguchi2.   

Abstract

In order to examine several factors that may affect the course and severity of transnasally induced Staphylococcus aureus pneumonia in mice, bacteria were prepared in a free suspension or bound to fetal mouse cells. Immunosuppression was induced in five strains of mice (ICR, C57BL/6, BALB/c, C3H/He and CBA/J) by injection of cyclophosphamide (200 mg/kg body weight), 2 days before infection. Impairment of mucociliary clearance was induced by intranasal instillation of formalin. Mice were then infected with various doses and strains of the organism. Although no significant differences were observed between either form of inoculum, pretreatment with formalin plus cyclophosphamide was associated with a significant increase in lung bacterial counts. In particular, cyclophosphamide treatment was associated with a high mortality in mice infected with several strains of S. aureus irrespective of their toxin production profiles. Histopathological examination demonstrated that in mice treated with formalin plus cyclophosphamide, clusters of bacteria were observed in lung parenchyma, associated with a mild accumulation of inflammatory cells at day 2 and extensive cell infiltration at day 7. CBA/J mice represented the most susceptible strain among those examined, with 10(4)- and 10(2)-fold higher bacterial counts in the lungs at days 3 and 5, respectively. These results indicate that neutropenia and impaired mucociliary clearance are major factors that influence the severity of S. aureus pneumonia in mice. Analysis of the role of genetic background in enhancement of vulnerability to infection is warranted in future studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535644     DOI: 10.1099/00222615-48-11-1005

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Ravi J Patel; Olaf Schneewind
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

2.  Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance.

Authors:  Charles M Robertson; Erin E Perrone; Kevin W McConnell; W Michael Dunne; Barrett Boody; Tejal Brahmbhatt; M Julia Diacovo; Nico Van Rooijen; Lisa A Hogue; Carolyn L Cannon; Timothy G Buchman; Richard S Hotchkiss; Craig M Coopersmith
Journal:  J Surg Res       Date:  2008-03-13       Impact factor: 2.192

3.  Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice.

Authors:  Janhavi Athale; Allison Ulrich; Nancy Chou MacGarvey; Raquel R Bartz; Karen E Welty-Wolf; Hagir B Suliman; Claude A Piantadosi
Journal:  Free Radic Biol Med       Date:  2012-08-23       Impact factor: 7.376

4.  Neutrophil-mediated oxidative burst and host defense are controlled by a Vav-PLCgamma2 signaling axis in mice.

Authors:  Daniel B Graham; Charles M Robertson; Jhoanne Bautista; Francesca Mascarenhas; M Julia Diacovo; Vivianne Montgrain; Siu Kit Lam; Viviana Cremasco; W Michael Dunne; Roberta Faccio; Craig M Coopersmith; Wojciech Swat
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

Review 5.  Animal models of polymicrobial pneumonia.

Authors:  Sami Hraiech; Laurent Papazian; Jean-Marc Rolain; Fabienne Bregeon
Journal:  Drug Des Devel Ther       Date:  2015-06-26       Impact factor: 4.162

6.  Phenol-soluble modulin α4 mediates Staphylococcus aureus-associated vascular leakage by stimulating heparin-binding protein release from neutrophils.

Authors:  Lin Li; Yaya Pian; Shaolong Chen; Huaijie Hao; Yuling Zheng; Li Zhu; Bin Xu; Keke Liu; Min Li; Hua Jiang; Yongqiang Jiang
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

7.  Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections.

Authors:  Adam J Plaunt; Sasha J Rose; Jeong Yeon Kang; Kuan-Ju Chen; Daniel LaSala; Ryan P Heckler; Arielle Dorfman; Barrett T Smith; Donald Chun; Veronica Viramontes; Antonio Macaluso; Zhili Li; Yuchen Zhou; Lilly Mark; Jessica Basso; Franziska G Leifer; Michel R Corboz; Richard W Chapman; David Cipolla; Walter R Perkins; Vladimir S Malinin; Donna M Konicek
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.